GlassScriptPhysician profile
Charles Edward Jaffe
NPI 1285628982
$19,701.88
in general payments reported to CMS, 2019-2025
52 companies · $2,388 in 2025
The $2,388 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,757 · 2020: $2,521 · 2021: $3,057 · 2022: $3,154 · 2023: $3,369 · 2024: $2,456 · 2025: $2,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,026 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,025.50 |
| Education | $187.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,310.33 | 2019-2025 | Opsumit, Xarelto, Uptravi |
| Pfizer INC. | $1,548.28 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,412.04 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,315.57 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $1,150.02 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $957.43 | 2019-2025 | Lifevest |
| Abbott Laboratories | $933.74 | 2019-2025 | Cardiomems, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Astrazeneca Pharmaceuticals LP | $901.46 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $891.90 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $848.50 | 2019-2025 | Watchman Flx, Watchman Access System |
| Amarin Pharma, INC. | $643.57 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $556.99 | 2022-2025 | Verquvo, Capvaxive |
| Novo Nordisk INC | $516.64 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Esperion Therapeutics, INC. | $479.42 | 2020-2024 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $427.82 | 2021-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $405.65 | 2022-2025 | Onpattro |
| Abiomed | $364.43 | 2022-2025 | Impella |
| Sanofi-Aventis U.S. LLC | $352.79 | 2019-2024 | |
| Lexicon Pharmaceuticals, INC. | $343.56 | 2023-2024 | Inpefa |
| Impulse Dynamics (USA) INC. | $287.25 | 2022-2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $264.70 | 2019-2025 | Evkeeza, Praluent |
| Heartflow, INC. | $261.77 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $259.42 | 2022-2024 | Uptravi, Opsumit |
| Preventric Diagnostics, INC. | $250.24 | 2021 | |
| Scpharmaceuticals INC. | $224.02 | 2024-2025 | |
| Astellas Pharma US INC | $217.27 | 2019-2022 | |
| Lundbeck LLC | $194.24 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $193.61 | 2021-2023 | Venclose Maven Catheter |
| Kowa Pharmaceuticals America, INC. | $188.84 | 2019-2023 | Livalo |
| Corcept Therapeutics | $171.22 | 2025 | Korlym |
| Kiniksa Pharmaceuticals, LTD. | $144.48 | 2021-2023 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $129.44 | 2019-2021 | |
| Edwards Lifesciences Corporation | $87.89 | 2020-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amryt Pharma Holdings LTD | $39.43 | 2020-2021 | |
| Bridgebio Pharma, INC. | $38.95 | 2025 | Attruby |
| Azurity Pharmaceuticals, INC. | $38.75 | 2023-2024 | Edarbi, Edarbyclor |
| Lantheus Medical Imaging, INC. | $34.40 | 2020-2024 | |
| Koya Medical, INC. | $34.12 | 2025 | Dayspring, Koya Medical |
| Chiesi USA, INC. | $33.91 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $31.02 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $25.19 | 2023 | Inspire |
| Daiichi Sankyo INC. | $24.67 | 2022 | |
| Ionis Pharmaceuticals, INC. | $21.79 | 2025 | Tryngolza |
| Philips North America LLC | $19.01 | 2021 | |
| Livanova USA, INC. | $18.00 | 2019 | |
| Glaxosmithkline, LLC. | $16.97 | 2025 | Shingrix, Arexvy |
| Medtronic, INC. | $16.90 | 2021 | |
| Allergan, INC. | $16.67 | 2019 | |
| Medtronic Vascular, INC. | $15.26 | 2019 | |
| Braemar Manufacturing, LLC | $15.01 | 2019 | |
| Csl Behring | $14.83 | 2021 | |
| Medicure Pharma INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.